Clinical Trial
doi: 10.1016/0168-8227(95)01104-l.
Clinical evaluation of glimepiride (HOE490) in NIDDM, including a double blind comparative study versus gliclazide
Affiliations
- PMID: 8529507
- DOI: 10.1016/0168-8227(95)01104-l
Item in Clipboard
Clinical Trial
Clinical evaluation of glimepiride (HOE490) in NIDDM, including a double blind comparative study versus gliclazide
Diabetes Res Clin Pract.
1995 Aug.
Abstract
In order to investigate the clinical usefulness of glimepiride in NIDDM, some clinical trials were conducted. In a double-blind comparative study versus gliclazide, glimepiride was as efficacious as gliclazide. However, a subgroup analysis suggested glimepiride may have been more effective in severe patients treated by large doses of glibenclamide.
Similar articles
-
[Clinical efficacy of glimepiride].Nihon Rinsho. 1997 Nov;55 Suppl:152-7. Nihon Rinsho. 1997. PMID: 9434460 Review. Japanese. No abstract available.
-
Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.Horm Metab Res. 1996 Sep;28(9):426-9. doi: 10.1055/s-2007-979831. Horm Metab Res. 1996. PMID: 8911977 Clinical Trial.
-
Glimepiride: new preparation. Just another hypoglycaemic sulphonylurea agent.Prescrire Int. 1998 Aug;7(36):106-7. Prescrire Int. 1998. PMID: 10342947
-
Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.Diabetes Care. 1996 Nov;19(11):1194-9. doi: 10.2337/diacare.19.11.1194. Diabetes Care. 1996. PMID: 8908379 Clinical Trial.
-
Comparison of efficacy, secondary failure rate, and complications of sulfonylureas.J Diabetes Complications. 1994 Oct-Dec;8(4):201-3. doi: 10.1016/1056-8727(94)90044-2. J Diabetes Complications. 1994. PMID: 7833494 Review.
Cited by
-
Efficacy and Safety of Gliclazide versus Glimepiride in T2DM Patients: A Systematic Review.Indian J Endocrinol Metab. 2025 May-Jun;29(3):260-267. doi: 10.4103/ijem.ijem_372_24. Epub 2025 Jun 28. Indian J Endocrinol Metab. 2025. PMID: 40688616 Free PMC article. Review.
-
Glimepiride reduces CD14 expression and cytokine secretion from macrophages.J Neuroinflammation. 2014 Jun 21;11:115. doi: 10.1186/1742-2094-11-115. J Neuroinflammation. 2014. PMID: 24952384 Free PMC article.
-
Effects of glimepiride on insulin and glucagon release from isolated rat pancreas at different glucose concentrations.Acta Diabetol. 1996 Mar;33(1):25-9. doi: 10.1007/BF00571936. Acta Diabetol. 1996. PMID: 8777281
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
